Abstract
The following review outlines the physiological outcome of VIP and VIP gene manipulations. Previously, we reviewed the various VIP receptors associated with biological functions ranging from growth regulation, sexual function, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP-based drug design is discussed below.
Keywords: vip receptors, vip, vasoactive intestinal peptide, drug design, vip family
Current Pharmaceutical Design
Title: VIP and Drug Design
Volume: 9 Issue: 6
Author(s): Illana Gozes and Sharon Furman
Affiliation:
Keywords: vip receptors, vip, vasoactive intestinal peptide, drug design, vip family
Abstract: The following review outlines the physiological outcome of VIP and VIP gene manipulations. Previously, we reviewed the various VIP receptors associated with biological functions ranging from growth regulation, sexual function, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP-based drug design is discussed below.
Export Options
About this article
Cite this article as:
Gozes Illana and Furman Sharon, VIP and Drug Design, Current Pharmaceutical Design 2003; 9 (6) . https://dx.doi.org/10.2174/1381612033391667
DOI https://dx.doi.org/10.2174/1381612033391667 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry 1,3,4-Thiadiazole Based Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Involvement of Targeting and Scaffolding Proteins in the Regulation of the EGFR/Ras/MAPK Pathway in Oncogenesis
Current Signal Transduction Therapy Evaluation of Direct Effect of Testosterone on NGEP and LM O1 Expression in LNCaP Prostate Cancer Cells
Current Biomarkers (Discontinued) Nanoparticles for Cancer Targeting: Current and Future Directions
Current Drug Delivery Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Targeting Heat Shock Protein 90 for Malaria
Mini-Reviews in Medicinal Chemistry Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery Anti-Angiogenic Peptides for Cancer Therapeutics
Current Pharmaceutical Biotechnology Endoglin-Targeted Cancer Therapy
Current Drug Delivery Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Current Pharmaceutical Design Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets Morphological and Functional Characteristic of Senescent Cancer Cells
Current Drug Targets Anti-inflammatory Property of AMP-activated Protein Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer
Medicinal Chemistry Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones
Anti-Cancer Agents in Medicinal Chemistry Flavonoids as Multi-Target Compounds in Drug Discovery
Mini-Reviews in Organic Chemistry TGF-ß / Smad Signaling in Prostate Cancer
Current Drug Targets Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modulation of Notch Signaling as a Therapeutic Approach for Liver Cancer
Current Gene Therapy